Health Care/Hospital

DaVita enters into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador

Expansion would make DaVita the largest dialysis services provider in Latin America DENVER, March 5, 2024 /PRNewswire/ -- DaVita Inc (NYSE: DVA), a leading provider of kidney care services, today announced that it has agreed to terms on the expansion of its international operations inBrazil and ...

2024-03-05 22:00 3211

Zymo Research Pioneers a Breakthrough in Large-scale Animal-free RNase A Production

IRVINE, Calif., March 5, 2024 /PRNewswire/ -- In a groundbreaking development, Zymo Research, a leader in biotechnology innovation, has revolutionized large-scale production of animal-free recombinant RNase A ( PureRec RNase A), a challenge that persisted for over half a century. This breakthroug...

2024-03-05 22:00 1332

YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries

GAITHERSBURG, Md., March 5, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disea...

2024-03-05 21:00 2371

Angel Yeast Hosts Webinar with PPTI to Promote Sustainable Development of Proteins

SHANGHAI, March 5, 2024 /PRNewswire/ -- Angel Yeast , (SH600298), the world's leading yeast manufacturer, recently successfully hosted a webinar event with Protein Production Technology International (PPTI), a digital publication dedicated to the alternative proteins sp...

2024-03-05 21:00 1726

WuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change Assessment

SHANGHAI, March 5, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced it has been recognized for outstanding performance in the 2023 Climate Change Assessment conducted by the global environ...

2024-03-05 21:00 1150

IRBM Expands Global Reach in Drug Discovery with New Boston Office

Strategic Growth and Increased Visibility Set to Enhance IRBM's Leadership Position ROME, March 5, 2024 /PRNewswire/ -- IRBM, an integrated drug discovery Contract Research Organization (CRO), announces its global expansion with a new office inBoston, Massachusetts, a cornerstone for biotechnolo...

2024-03-05 20:24 1459

One Million Global Healthcare Seekers Embrace MedicalTourism.com: Medical Tourism Magazine Leads the Way

WEST PALM BEACH, Fla., March 5, 2024 /PRNewswire/ -- Launched in 2023 by The Medical Tourism Association, DarwinAI (Artificial Intelligence) is an AI-enabled marketing technology revolutionizing the medical tourism landscape. Darwin AI uses powerful AI-enabled algorithms to drive brand awareness,...

2024-03-05 16:00 1220

Cetaphil® Strengthens Ties with the Malaysian Community through Collaborative Partnership with Mira Filzah as the New Face of the Brand in 2024

KUALA LUMPUR, Malaysia, March 5, 2024 /PRNewswire/ -- Cetaphil®, the No.1 dermatological skincare brand inMalaysia, proudly announces a significant partnership in anticipating of the holy month of Ramadan. The brand is thrilled to unveil the newest face of Cetaphil® for 2024, the versatile Malays...

2024-03-05 14:58 1257

Innovent and AnHeart Therapeutics Announce the NMPA of China Has Accepted Second NDA for Taletrectinib for First-Line Treatment of ROS1-Positive Lung Cancer

ROCKVILLE, Md. and SUZHOU, China, March 5, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology an...

2024-03-05 13:35 1597

First Patient Treated in Phase 2 GvHD Trial

MELBOURNE, Australia, March 5, 2024 /PRNewswire/ -- Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics, confirms that the first patient has been enrolled and treated in its Phase 2 clinical trial ofCYP-001...

2024-03-05 10:08 1340

Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform

MELBOURNE, Australia, March 5, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire radioisotope production technology firm ARTMS Inc. (ARTMS), its advanced cyclotron-based isotope production platform, manuf...

2024-03-05 07:01 1336

Formosa Pharmaceuticals and AimMax Therapeutics Receive FDA Approval for Clobetasol Propionate Ophthalmic Suspension 0.05%, for the Treatment of Post-Operative Inflammation and Pain Following Ocular Surgery

TAIPEI, March 4, 2024 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals (6838.TWO) and AimMax Therapeutics (United States) announced today that the U.S. Food and Drug Administration (FDA) has approved clobetasol propionate ophthalmic suspension 0.05% (APP13007), for the treatment of post-opera...

2024-03-05 06:55 1250

Neurophet introduces AI-powered brain imaging analysis technology at AD/PD 2024

- Showcases brain imaging analysis technology with key products Neurophet AQUA and Neurophet SCALE PET - Aims to commercialize ARIA analysis and amyloid-positive prediction technology SEOUL, South Korea, March 4, 2024 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company f...

2024-03-04 22:00 1079

ACROBiosystems Launches New Initiative to Support Cell and Gene Manufacturers

NEWARK, Calif., March 4, 2024 /PRNewswire/ -- ACROBiosystems, one of the leading providers of innovative tools and solutions used from discovery to the clinic, has announced a new corporate initiative to supportex vivo cell manufacturing and manufacturers of innovative cell and gene therapies. I...

2024-03-04 22:00 905

Optimum Nutrition Launches New Global Marketing Campaign "Unlock More You"

The campaign taps into the universal human desire to unlock more within ourselves, regardless of athletic ability or achievement DUBLIN, March 4, 2024 /PRNewswire/ -- Optimum Nutrition, the world's #1 sports nutrition brand1 from Glanbia Performance Nutrition (GPN), today releases its new global...

2024-03-04 22:00 2066

Cyient Partners with MassMedic to Accelerate MedTech Innovation

HYDERABAD, India, March 4, 2024 /PRNewswire/ -- Cyient, a global Intelligent Engineering and Technology Solutions company, is thrilled to announce its membership with the Massachusetts Medical Device Industry Council (MassMedic), the largest regional MedTech association inthe United States. This ...

2024-03-04 22:00 1125

KCI, a subsidiary of Samyang Group, won 'Platinum Medal' in EcoVadis ESG Rating, Ranked in the Top 1% worldwide

* Evaluated firstly as a L'Oreal partner in 2013 and achieved the highest rating in 11 years * Efforts to establish an ESG committee, reinforce labor and human rights management, and improve management of partners SEOUL, South Korea, March 4, 2024 /PRNewswire/ -- Samyang Group announced that ...

2024-03-04 21:30 939

Henlius Forecasts Profit in 2023: Achieving first full year of profitability, and ushering in a new phase of high-quality development

SHANGHAI, March 4, 2024 /PRNewswire/ -- Henlius (2696.HK) released a positive profit forecast. Based on the preliminary assessment of the unaudited consolidated management accounts for the year ended31 December, 2023 (the "Reporting Period") and the information currently available to the Board,it...

2024-03-04 21:19 1730

Milliken & Company Recognized Among the 2024 World's Most Ethical Companies®

SPARTANBURG, S.C., March 4, 2024 /PRNewswire/ -- Diversified global manufacturer Milliken & Company is proud to be included on the 2024 World's Most Ethical Companies list curated by Ethisphere, a leader in defining and advancing the standards of ethical business practices. This annual recognition...

2024-03-04 21:00 992

Landmark Clinical Approval for YOLT-201 Obtained by the NMPA

SHANGHAI, March 4, 2024 /PRNewswire/ -- YolTech Therapeutics, a biotech company developing in vivo gene editing therapies to treat rare genetic diseases, today announced the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) has officially  approved the YOLT-2...

2024-03-04 20:00 385
1 ... 10111213141516 ... 802

Week's Top Stories